Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q96HN2
UPID:
SAHH3_HUMAN
Alternative names:
IP(3)Rs binding protein released with IP(3) 2; Long-IRBIT; S-adenosyl-L-homocysteine hydrolase 3; S-adenosylhomocysteine hydrolase-like protein 2
Alternative UPACC:
Q96HN2; B4DIZ5; D9N155; O94917
Background:
Adenosylhomocysteinase 3, also known as S-adenosyl-L-homocysteine hydrolase 3, plays a crucial role in cellular metabolism by potentially regulating the activity of the sodium/bicarbonate cotransporter SLC4A4 and its sensitivity to magnesium ions. Unlike its homolog AHCYL1, it does not affect the sensitivity of ITPR1 to inositol 1,4,5-trisphosphate, highlighting its unique function in cellular processes.
Therapeutic significance:
Understanding the role of Adenosylhomocysteinase 3 could open doors to potential therapeutic strategies. Its distinct regulatory functions suggest it could be a target for modulating cellular metabolism and ion transport mechanisms, offering new avenues for drug discovery.